modalis @modalistx
Modalis is a Waltham MA/Tokyo based biotech company developing gene therapies for rare diseases with a novel CRISPR based epigenome editing technology. modalistx.com Waltham, MA Joined August 2019-
Tweets23
-
Followers75
-
Following16
-
Likes1
We are thrilled to announce a strategic partnership with SOLVE FSHD, along with successful strategic funding dedicated to advancing our MDL-103 for the treatment of facioscapulohumeral muscular dystrophy (FSHD).
Modalis has been selected as a finalist in the XPRIZE Healthspan FSHD Bonus Prize Competition and awarded research funds. #xprize businesswire.com/news/home/2025…
Happy New Year 2025! Excited to announce the new chapter of the collaboration!
Modalis Therapeutics has received an Orphan Drug Designation from the U.S. Food and Drug Administration for MDL-101, a treatment for congenital muscular dystrophy type 1A (LAMA2-CMD).
FDA Grants Rare Pediatric Disease Designation to MDL-101 for the treatment of congenital muscular dystrophy type 1a (LAMA2-CMD)
MODALIS to present its development progress at the Genome Editing Tx Summit.
Modalis will present process development data at the 16th Annual Bioprocessing Summit on Aug 20th.
Our development efforts towards LAMA2-CMD were featured. lama2.com/news/modlalis-…
Excited to share that a paper has been published on preclinical data from our lead program, MDL-101 ! businesswire.com/news/home/2024…
MODALIS to present MDL-101 data at 4th Next Generation Gene Therapy Vector conference.
Modalis announced our collaboration with Ginkgo Bioworks. Epigenome editing meets Synthetic Biology and the world-leading biofoundry capabilities! businesswire.com/news/home/2024…
We are excited to announce that MODALIS' mini-Cas9 patent has been granted in Japan. lnkd.in/gX9tBtjB
Modalis announced research collaboration with JCR pharma, a rare disease company, on an undisclosed CNS target. businesswire.com/news/home/2023…
Our scientist, John, is participating as one of the panel for the webinar. insights.bio/cell-and-gene-…
MODALIS is the sole company to put both ACTIVATION and SUPPRESSION into practical use. genengnews.com/topics/genome-…
Modalis to present at #asgct next week. See you in DC.
Lama2 India @Lama2India
0 Followers 23 Following 🌏 Searching for LAMA2 Muscular Dystrophy kids and cure! 🇮🇳 In the Population of 1.44 Billion, 60 kids only? Help us find more https://t.co/MWy5ioIr3y
シャムロック✨... @CloverYmm
538 Followers 482 Following 🏯 古い街道を和服を着て散歩し、古今が交錯する日本文化を体験するのが好きです🎴💖 また、日本のさまざまなユニークなテーマカフェに挑戦するのも好きです！「猫カフェ」の一杯を誰が拒否できるでしょうか？🐱☕️
ddaddaisuke @ddaddaisuke
0 Followers 25 Following
bharathmdfoundation @bharathmdfound1
329 Followers 1K Following A Parent Advocacy Organisation of Muscular Dystrophy. NGO under Sec 8 of MCA 2013. Awareness, Approach , Assistance,Prevention, Management and Cure.
kanberyakko @kanberyakko
180 Followers 346 Following Postdoctoral researcher at DZNE Neurologist at Uniklinik Bonn @LinkedIn: https://t.co/sViwUwmqg9
Tholioez @TholioezEoOtC
39 Followers 980 Following
響 @e9uUUdMFEEhzdo5
48 Followers 150 Following
舞茸 @quotezagzag
661 Followers 2K Following
YU @junkie00615305
104 Followers 156 Following 愛知県在住29歳♂/期待値💰/ギャンブル🎰🀄️🏇🚤🃏/バイク🏍️/サウナ♨️/らーめん🍜/アニメ/ナンピン/投資/仲良くしてください
meru @meruchan_823
27 Followers 38 Following 新NISAはインデックス投資メインです。株投資を始めた初心者です🔰 個別も勉強しながら楽しんでいます(*^^*) モダリス、北浜キャピタル応援してます
ニャパオ😻8783 ... @APcfIL6lIMPjFu6
280 Followers 447 Following 無言フォローお許しください。 株はスイングがメインで、デイトレはたまに（儲けた試しがないので、もうしません😭）ただのヘタクソ兼業投機家です😊よろしくお願いします🥺
青くろ @aquage_7
10K Followers 10K Following 上場企業（1000社くらい）のホームページ監視員。メインの話題は他の方にお任せして、TDnet以外のどうでもいいような開示やニュースをまったりつぶやきますので自己責任でお願いします。 ※諸般の事情（お昼寝等）により更新を怠ることも有りますので御容赦下さい。また週末は機能不全に陥ります。 ☆座右の銘：低時価総額こそは正義
N Y @NY5683824511596
35 Followers 32 Following
だいち @35Gekiatsu
3 Followers 6 Following
あさぱん🍞 @ASAPAN777
624 Followers 181 Following 写真家 Handmade作家 音楽 Fighters 大谷翔平 デコピン Dodgers Shohei Ohtani 🎸 BRUNO Mars 🎀 蔦屋重三郎 🌊 大河べらぼう 横浜流星 ありがた山 べらぼう
newgate @newgate28845627
54 Followers 53 Following
谷口誠 @Gu90TDMwQp46126
7 Followers 16 Following
ken_kasai @ken__kasai
11 Followers 22 Following
黒トンボ @kaikeisan3
137 Followers 292 Following 2024/12：80万スタート。今年の目標1,000万。25/2末140万。日米スイング〜中長期。レバ禁止。躊躇ない損切り、丁寧利確。
amn @amn30476886
4 Followers 18 Following
よしよし @SgG6LIwAmtIKluf
9 Followers 36 Following
シナモガエル @113183p
72 Followers 108 Following
株クラ🪼🤓 @kabu_kurage
343 Followers 147 Following 憂鬱な海月の株垢 総資産1000万突破からの総資産1000万→800万😭 モダリス、レボリューション、ワイハウ、GFAをくらって-700万😭 残金700万🤓 損失デカすぎ‼️ GFAを今は信じてる〜🤓
chappy y @chappyy136177
1 Followers 2 Following
温玉 @o93JY20c4611628
1 Followers 2 Following
chappy555 @chappy555555
0 Followers 6 Following
まるこ @fYG6VQLzgk92697
46 Followers 32 Following
こいのほし @Lychee_anna3
531 Followers 620 Following 性格が穏やかで、人に対して誠実で、いろいろなことが好きで、親切な人とはたくさん話せますね。🎀🎊 趣味：旅行、生け花、ガンダム、映画とアニメです。🎠💐 日語を勉強中🌸
Schneidercc93 @schneidercc93
1 Followers 40 Following
まふ。株1年生�... @mafu_kabu202409
723 Followers 459 Following 株1年生。24年9月から現物デイトレ→11月から信用はじめました！デイ&スイング。幼&小の子ども2人いるママ。子ども学費、老後資金&毎日ゆったり暮らす資金貯めたい。日本株のみ。米国株お休み。株勉強中。遅リプですが🙇ちゃんと読んでます🙇 子ども達の証券口座も運用しています。
へなちょこ @henatyoko1gou
187 Followers 131 Following モダリス、モドリス、モーアガリダス 全然あがらないから最近はデイトレ(´-ω-`) 仕事中にデイトレするとお腹が痛くなる気がしてトイレにいく時間が増えるー。
反逆のGYAN@ちなD... @ikedonmaru
151 Followers 251 Following 野球と競馬が趣味です。野球はベイスターズ。ギャンブルーの血が流れている⏩@NYANMARUCOIN
Lama2 India @ShrutiGupta2024
7 Followers 35 Following My daughter is 8 months old diagnosed with Lama2. Please connect with me to find a cure and search for fellow patients as lama2 is a rare genetic disorder.
マメタ犬の挑戦 @hAtPnVrxqHdWK5x
949 Followers 976 Following 陸上競技長距離、駅伝応援してます。自転車また乗りたいです。鮎釣り、山歩きも。リミックスホルダーです。
DMC-Lama2 France @FranceLama2
33 Followers 55 Following Familles touchées par la #dystrophie musculaire avec déficit en #mérosine. Gène #LAMA2 #CMD #DMC #congenitalmusculardystrophy #cureCMD #myopathy
Stichting Voor Sara @VoorSara
326 Followers 566 Following Stichting Voor Sara financiert onderzoek naar de zeer zeldzame spierziekte MDC1A. Ambassadeur Rico Verhoeven en vele strijders steunen Sara en haar lotgenoten.
Lama2 India @ShrutiGupta2024
7 Followers 35 Following My daughter is 8 months old diagnosed with Lama2. Please connect with me to find a cure and search for fellow patients as lama2 is a rare genetic disorder.
National Organization... @RareDiseases
40K Followers 3K Following #NORD has been the voice of the U.S. #RareDisease community for 40+ years strong. Official U.S. sponsor of #RareDiseaseDay. On Bluesky at @ https://t.co/D7PIT4k0Py
Muscular Dystrophy Ca... @MD_Canada
5K Followers 1K Following MDC's mission is to help people with neuromuscular disorders live life on their own terms. #WalkRollMDC #MuscularDystrophy FR: @Action_Musclee
Cure CMD @CureCMD
656 Followers 157 Following Cure CMD’s mission is to advance research toward treatments for congenital muscular dystrophies and empower those living with CMD.
Springer Nature @SpringerNature
82K Followers 2K Following Leading research publisher empowering researchers, educators, and health professionals with our trusted brands for 180+ years. Site notice https://t.co/JUoUEHImEB
Cell @CellCellPress
262K Followers 603 Following Cell aims to publish the most exciting and provocative research in biology. Posts by Scientific Editors on the Cell Editorial team.
Nature Portfolio @NaturePortfolio
2.2M Followers 2K Following Nature Portfolio’s high-quality products and services across the life, physical, chemical and applied sciences is dedicated to serving the scientific community.
J. Keith Joung @JKeithJoung
5K Followers 540 Following Lead Translator @arenabioworks, formerly Professor of Pathology (on leave, 2023-2025) @HarvardMed, #geneediting, #CRISPR; views expressed are my own
David R. Liu @davidrliu
74K Followers 64 Following Professor at Harvard, Broad Institute, & HHMI. Our lab integrates chemistry & evolution to illuminate biology & enable new therapeutics. IG/Threads: @davidrliu1
edigene @edigene_corp
17 Followers 1 Following
Nature Biotechnology @NatureBiotech
318K Followers 2K Following Publishing the best of biotech science and business. Find us on Bluesky, Facebook & Instagram. Part of @SpringerNature and @NaturePortfolio.
The CRISPR Journal @CRISPRjournal
22K Followers 891 Following Cutting-edge peer-reviewed research and analysis on genome editing for the global CRISPR community. EIC @crisprchef | Exec Ed @kevinadavies @liebertpub
CRISPR News 🧬 @CRISPR_News
35K Followers 566 Following The latest CRISPR breakthroughs @crispr-news.bsky.social
Trends for United States
You might like
